1 / 53

National Institute of Public Health

National Institute of Public Health. Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis. Cuernavaca Mexico. Stefano Bertozzi March, 2008 Cape Town. Costs and Costing. Costs perspectives: Accountants vs. Economists. Value of fixed assets vs. Fixed Cost.

crose
Download Presentation

National Institute of Public Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Institute of Public Health Costs and CostingCost Benefit Analysis Cost Effectiveness Analysis Cuernavaca Mexico Stefano Bertozzi March, 2008 Cape Town

  2. Costs and Costing

  3. Costs perspectives: Accountants vs. Economists • Value of fixed assets vs. Fixed Cost • Total Cost (TC)= Cost of producing a specific amount of product/service • Fixed Cost (FC)= Cost that does not vary with the quantity produced in the short run (one year) • Variable Cost (VC)= Cost that varies with the quantity produced

  4. Costs perspectives: Accountants vs. Economists • Value of assets vs. Fixed Cost • Depreciation vs. Discounting

  5. 100 90 80 70 60 50 40 30 20 10 0 1 5 10 15 20 25 30 0%; Total 3,000 3%; Total 2,019 10%; Total 1,037

  6. Costs perspectives: Accountants vs. Economists • Value of assets vs. Fixed Cost • Depreciation vs. Discounting • Financial Cost vs. OpportunityCost • The cost of any activity measured in terms of the benefit forgone from the next best alternative

  7. Costs perspectives: Accountants vs. Economists • Value of assets vs. Fixed Cost • Depreciation vs. Discounting • Financial Cost vs. Opportunity Cost • Minimize leaks and auditing problems vs. Maximize efficiency • Average Cost vs. Marginal Cost • Average Cost: total cost /n • Marginal Cost: total cost [n] – total cost [n-1]

  8. Average Cost Marginal Cost 25 20 15 Cost 10 5 0 1 5 10 15 20 25 30 35 40 45 units number

  9. ¿Why cost? • Evaluate efficiency in two equivalent programs • Which one provides greater benefits, given a fixed amount of resources • Identify principal cost categories, to guide managers towards potential savings • Forecast costs • Set user fees • Perform cost-benefit or cost-effectiveness analyses

  10. ¿What is cost? It is the value of the resources used to produce something (not necessarily the amount paid for those resources)

  11. Key costing aspects A) Perspective B) Time Frame C) Analytic horizon D) Data availability

  12. A) Perspective • User/beneficiary: (e.g. transport costs, user fees, opportunity cost for the family, etc.) • Provider: (e.g. treatment and hospitalization costs; costs of running a school) • Social: all costs, regardless of who pays, including positive and negative externalities (non-compensated work, changes in productivity, in the savings rate, etc.)

  13. B) Time Frame • Period of study for data collection • Need to capture temporal variation (typically one year)

  14. C) Analytic Horizon • Period of time in which costs and effects are modeled • For HIV, typically a lifetime, if not more…

  15. Cost estimation can be divided into three parts: • Identification of the relevant costs • Quantity of resources used (Qs) • Value of resources used (C=P*Q) P= price Q= quantity

  16. Definitions and Costs Categorization

  17. Costs & Money • Not all costs are expenses • Caring/nursing time • Time of volunteers • Donations • Costs included depend on the perspective

  18. Net Costs • The net costs of one intervention are:(Total Costs of the intervention) – (Value of savings generated)

  19. Two types of inputs to classify • recurrent inputs: inputs that are used in less than one year • capital inputs : inputs that last more than one year

  20. Cost - Benefit Analysis

  21. What is CBA? • Values the consequences of an intervention in monetary terms • Enables comparison of interventions in different sectors (e.g. health vs. education vs. infrastructure) • If a project as a whole produces more benefits than costs, it is worth doing it. Otherwise, no.

  22. Cost-Benefit Analysis Implementation Obstacles : • Difficult and controversial to allocate monetary value to changes in: Morbidity and mortality (value of a life…)

  23. Cost – Effectiveness Analysis

  24. Cost – Effectiveness Analysis • Only useful when comparing costs and consequences of two or more alternatives • Only useful when the competing alternatives produce a common result • e.g.: • HIV infections averted • years of additional life (on ART) • child deaths from malaria

  25. Cost – Effectiveness Analysis Identify a common outcome for the alternatives to be compared

  26. Steps to consider in CEA… IDENTIFICATION OF RELEVANT ALTERNATIVES • CEA makes no sense when analyzing only one alternative • It estimates cost per unit of effect • This value alone does not tell you if an intervention is a “good buy”, but… $/DALY

  27. Steps to consider in CEA… IDENTIFICATION OF RESULT MEASURES • Intermediate • Condom use at last 3 intercourse • Final • Fertility • STI incidence • HIV incidence

  28. Steps to consider in CEA… • Adverse effects of the intervention • Costing • Program/Intervention Costs • Averted costs • Externalities (e.g. productivity losses of third parties)

  29. Design • Conceptual Model • Flow diagram of the relevant interventions • Decision Tree or other way to model the process (Markov Model) • The quality of the results depends on the quality of the model • Parameter uncertainty can be readily addressed, not so for uncertainty related to structure of the model

  30. Survive Infected Die Male Circ Healthy Intervention Survive Infected Die No MC Healthy

  31. Average clinical benefit as a function of adherence Vit A ART 100% % ADHERENCIA

  32. Sensitivity Analysis • Model variables have different levels of uncertainty • In absence of empirical data, one must make informed assumptions (e.g. about the effectiveness of new technologies) • When there are methodological debates different scenarios can be modeled (e.g. discount rate, productivity losses)

  33. Sensitivity Analysis • Explores the sensitivity of the model’s results to variation in values of input parameters • Tests the robustness of the conclusions by varying uncertain parameters across their “plausible” range

  34. Types of Sensitivity Analysis • Univariate • Multivariate • Scenarios (optimistic, baseline, pessimistic) • Probabilistic • Threshold Analysis

  35. Cost-Effectiveness Measures • Cost per unit of produced effect • A lower cost per unit is preferred

  36. $500/200 cases prevented = 2.5 on average $100/10 cases= 10 incremental 600 500 400 Costs 300 200 100 0 0 50 100 150 200 250 Effects FIGURE 5.5 Drummond

  37. Interpretation of Cost-Effectiveness measures • Dominance • Program A dominates B when its effectiveness is greater and its cost lower than program B

  38. 600 500 400 Costs B 300 A 200 100 0 0 50 100 150 200 250 Effects FIGURE 5.5 Drummond

  39. If ART has no impact on prevention... $180 $163 $145 US$ per life year saved $19 $168 Adhere MTCT+ BPL BPL+Dis If ART slows prevention... If ART helps prevention... Government cost $200 $150 $100 $50 $0 $50 $100 US$ per life year lost $150 $200 BPL+TM

  40. Cost-benefit and cost-effectiveness analyses help to decide which basket of interventions is the best to achieve a specific objective. But… not only should we know WHAT to implement, but also, HOW.

  41. ¿Why cost? • Evaluate efficiency in two equivalent programs • Which one provides greater benefits, given a fixed amount of resources • Identify principal cost categories, to guide managers towards potential savings • Forecast costs • Set user fees • Perform cost-benefit or cost-effectiveness analyses

  42. Efficient Allocation vs. Efficient Production • Allocative efficiency • Allocate resources to those interventions that provide the maximum “value for money” • CBA & CEA • Technical Efficiency • Make the most of the allocated funds to each intervention • Efficiency Analysis and its determinants

  43. Y Y2 Intervention 2 Y1 X1 X Production Function and Allocative Efficiency Intervention 1 Benefit Investment

  44. Allocative Efficiency • Cost-effectiveness analyses typically assume: • Results are reproducible in different contexts and scales • Interventions are implemented at their efficiency frontier • A “cost-effective” intervention can become very “cost-ineffective” if implemented inefficiently

  45. Y Y3 Y2 Y1 X1 X Production Function and Technical Efficiency Benefit Investment

  46. Programs poorly managed: Enormous variation in unit costs $1000 Mexico Uganda Russia India South Africa $100 Cost per VCT Completed (unit cost) $10 $1 0 10 100 1000 10,000 Annual Clients Completing VCT (scale) 66

  47. Programs poorly managed: Enormous variation in unit costs $1000 Mexico Uganda Russia India South Africa $100 Cost per VCT Completed (unit cost) $10 $1 0 10 100 1000 10,000 Annual Clients Completing VCT (scale) 67

  48. Programs poorly managed: Enormous variation in unit costs $1000 Mexico Uganda Russia India South Africa $100 Cost per VCT Completed (unit cost) $10 $1 0 10 100 1000 10,000 Annual Clients Completing VCT (scale) 68

  49. Technical efficiency in VCT: 17 sites in Mexico

More Related